Genesis HealthCare (GEN) Tops Q4 EPS by 2c

Genesis HealthCare (NASDAQ: GEN) reported Q4 EPS of $0.45, $0.02 better than the analyst estimate of $0.43. Revenue for the quarter came in at $936 million versus the consensus estimate of $933 million.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Lennar Corp. (LEN) Misses Q2 EPS by 1c
• RH (RH) Tops Q1 EPS by 12c